88% Phenol vs 10% NaOH in the treatment of Ingrown toe-nail

Comparison of 88% phenol and 10% sodium hydroxide chemical matricectomy along with partial nail avulsion for the management of ingrowing toe nail

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/11/004164

Enrollment

Registered

2013-11-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L600- Ingrowing nail Health Condition 2: null- Patients with Ingrown toe nails

Interventions

Intervention1: Comparison of efficacy of 88% Phenol solution vs 10% NaOH solution for lateral matricectomy in the treatment of ingrown toenail.: Phenol (88% solution) is one of the commonest agents us

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with a clinical diagnosis of ingrown toenail, who are symptomatic presenting to the dermatology clinic of GTB hospital, with ages between 18 to 60 years. 2. Patients willing to participate in the study according to the protocol.

Exclusion criteria

Exclusion criteria: 1. Those with significant peripheral arterial disease or history of chronic smoking 2. Known allergy to the chemical agents being used 3. Conditions associated with delayed wound healing e.g. Diabetes Mellitus. 4. Pregnant or lactating women. 5. Patients not consenting for surgical intervention or for inclusion in the study protocol

Design outcomes

Secondary

Measure	Time frame
2. Cure: This will be defined as healing along with absence of pain (score 0). The number of patients cured within each group will be recorded.Timepoint: Assessed at each visit as per protocol.;3. Recurrence: All the patients will be followed up for a minimum period of one year. Any reappearance of pain, discharge, inflammation or swelling of the nail fold in a patient who had previously been cured will counted as a recurrence.Timepoint: Assessed at each visit (as per protocol) upto a maximum of ONE YEAR	—

Measure

Time frame

2. Cure: This will be defined as healing along with absence of pain (score 0). The number of patients cured within each group will be recorded.Timepoint: Assessed at each visit as per protocol.;3. Recurrence: All the patients will be followed up for a minimum period of one year. Any reappearance of pain, discharge, inflammation or swelling of the nail fold in a patient who had previously been cured will counted as a recurrence.Timepoint: Assessed at each visit (as per protocol) upto a maximum of ONE YEAR

—

Primary

Measure	Time frame
1. Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.Timepoint: 1. Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.	—

Measure

Time frame

1. Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.Timepoint: 1. Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.

—

Countries

India

Contacts

Public ContactDr Chander Grover

University College of Medical Sciences and GTB Hospital

chandergroverkubba@rediffmail.com9818065653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026